Royalty Pharma
RPRX
$27.41
Share price
3.87%
Change (1 day)
-17.37%
Change (1 year)
Categories
P/S ratio for Royalty Pharma (RPRX)
P/S ratio as of June 2024 (TTM): 7.05
According to Royalty Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.04575. At the end of 2023 the company had a P/S ratio of 7.15.
P/S ratio history for Royalty Pharma from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 7.15 | -8.2% |
| 2022 | 7.79 | 4.23% |
| 2021 | 7.48 | -18.32% |
| 2020 | 9.15 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 4.39 | -37.71% | 🇺🇸 USA |
 Eli Lilly LLY | 21.6 | 205.98% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | 2.57 | -63.51% | 🇺🇸 USA |